EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells

Aditya Venkatesh iD, Taylor McKenty, Syed Ali, Donna Sonntag, Shobha Ravipaty, Yanyan Cui, Deirdre Slate, Qian Lin, Anne Christiansen, Sarah Jacobson, Jacob Kach, Kian Huat Lim und 9 weitere

Nucleic Acid Therapeutics · 2024

DOI: 10.1089/nat.2024.0022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2024. Verfasst von Aditya Venkatesh und 20 weiteren Autor:innen. Beteiligte Einrichtung: Stoke Therapeutics, Bedford, Massachusetts, USA. Hauptthemen laut MEDLINE: GTP Phosphohydrolases, Optic Atrophy, Autosomal Dominant, Oligonucleotides, Antisense, Retina. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal dominant optic atrophy (ADOA) is an inherited optic neuropathy most frequently associated with OPA1 mutations. Most variants result in haploinsufficiency, and patient cells express roughly half of the normal levels of OPA1 protein. OPA1 is a mitochondrial GTPase that is essential for normal mitochondrial function. We identified and characterized STK-002, an antisense oligonucleotide (ASO) designed to prevent the incorporation of a naturally occurring alternatively spliced nonproductive exon in OPA1 . STK-002 dose dependently reduced the inclusion of this exon, and increased OPA1 protein in human cells, including ADOA patient-derived fibroblasts. ADOA patient cells manifest reduced mitochondrial respiration, and treatment with STK-002 improved the parameters of mitochondrial respiratory function in these cells. Since STK-002 increases OPA1 through the wild-type allele, we assessed retinal OPA1 in wild-type cynomolgus monkeys and rabbits after intravitreal administration of STK-002 or a rabbit-specific surrogate. Increased OPA1 protein was produced in retinal tissue in both species at 4 weeks after ASO injection and persisted in monkeys at 8 weeks. STK-002 and enhanced OPA1 immunofluorescence were visualized in retinal ganglion cells of cynomolgus monkeys treated with the ASO. Cumulatively, these data support the progression of STK-002 toward the clinic as the first potential disease-modifying treatment for ADOA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP PhosphohydrolasesOptic Atrophy, Autosomal DominantOligonucleotides, AntisenseRetinaMitochondriaMacaca fascicularisAnimalsHumansRabbitsFibroblastsExonsMutation

Stichwörter der Autor:innen

ADOAASOOPA1exon splicinghaploinsufficiencymRNA

Substanzen

GTP PhosphohydrolasesOligonucleotides, AntisenseOPA1 protein, human

Autor:innen und Institutionen

  • Stoke Therapeutics, Bedford, Massachusetts, USA.
  • Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID-Profile: Aditya Venkatesh

Förderung

  • NEI NIH HHS

Zitieren

APA

Venkatesh, A., McKenty, T., Ali, S., Sonntag, D., Ravipaty, S., Cui, Y., Slate, D., Lin, Q., Christiansen, A., Jacobson, S., Kach, J., Lim, K. H., Srinivasan, V., Zinshteyn, B., Aznarez, I., Huryn, L. A., Li, Z., Hufnagel, R. B., Liau, G., …, & Hoger, J. (2024). Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2024.0022

Vancouver

Venkatesh A, McKenty T, Ali S, Sonntag D, Ravipaty S, Cui Y, et al. Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells. Nucleic Acid Therapeutics. 2024. doi:10.1089/nat.2024.0022

BibTeX
@article{Venkatesh2024,
  author = {Venkatesh, Aditya and McKenty, Taylor and Ali, Syed and Sonntag, Donna and Ravipaty, Shobha and Cui, Yanyan and Slate, Deirdre and Lin, Qian and Christiansen, Anne and Jacobson, Sarah and Kach, Jacob and Lim, Kian Huat and Srinivasan, Vaishnavi and Zinshteyn, Boris and Aznarez, Isabel and Huryn, Laryssa A and Li, Zhiyu and Hufnagel, Robert B and Liau, Gene and Anderson, Karen and Hoger, Jeff},
  title = {Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells},
  journal = {Nucleic Acid Therapeutics},
  year = {2024},
  doi = {10.1089/nat.2024.0022}
}
Kostenlos starten →